1. Home
  2. SQM vs ILMN Comparison

SQM vs ILMN Comparison

Compare SQM & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sociedad Quimica y Minera S.A.

SQM

Sociedad Quimica y Minera S.A.

HOLD

Current Price

$73.94

Market Cap

17.6B

Sector

Industrials

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$134.21

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQM
ILMN
Founded
1968
1998
Country
Chile
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.6B
20.5B
IPO Year
1993
2000

Fundamental Metrics

Financial Performance
Metric
SQM
ILMN
Price
$73.94
$134.21
Analyst Decision
Buy
Hold
Analyst Count
10
17
Target Price
$66.85
$125.71
AVG Volume (30 Days)
1.7M
2.1M
Earning Date
03-03-2026
02-05-2026
Dividend Yield
2.67%
N/A
EPS Growth
N/A
N/A
EPS
1.84
4.46
Revenue
$4,326,111,000.00
$4,288,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$22.11
$2.79
P/E Ratio
$43.19
$30.36
Revenue Growth
N/A
N/A
52 Week Low
$29.36
$68.70
52 Week High
$86.13
$155.53

Technical Indicators

Market Signals
Indicator
SQM
ILMN
Relative Strength Index (RSI) 45.18 40.12
Support Level $75.00 $147.57
Resistance Level $79.31 $153.48
Average True Range (ATR) 3.18 5.44
MACD -1.42 -2.30
Stochastic Oscillator 7.16 8.54

Price Performance

Historical Comparison
SQM
ILMN

About SQM Sociedad Quimica y Minera S.A.

Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: